The Earlier the Better: Probing Malignancies in Newborns
(L-R) Prof.Wolfgang Holzgreve, Prof. Marek Glazerman, Prof. Israel Meisner
Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses. An international data registry on fetal tumors is already in progress, which will assist in treating malignant conditions in both fetuses and newborns. Prof. Israel Meisner, head of RMC's Obstetric Ultrasound Unit, said tumors such as Neuroblastoma can be fully cured if discovered early in a fetus, and he believes this registry is important.
The data registry project was inaugurated during a conference at Rabin Medical Center on Women's Healthcare organized by GE Healthcare Israel, headed by Tony Bachar, and by the Rabin Medical Center's Women's Hospital, headed by Prof. Marek Glazerman. Among the honored guests present was Prof. Wolfgang Holzgreve, head of obstetrics and gynecology at the renowned University of Basel in Switzerland.
Related Articles
Advancing Women's Healthcare in the Arab Israeli Population
In continued support and friendship with Rabin Medical Center, Harold and Tamar Snyder have generously funded an internship in the field of gynecology.
Male fetuses are more trouble
Judy Siegel-Itzkovich, THE JERUSALEM POST
It isn't an "old wives' tale" that carrying a male fetus is more "troublesome" than carrying a female fetus, according to research encompassing over 66,000 women who gave birth at the Rabin Medical Center (RMC) in Petah Tikva between 1995 and 2006.
Lifesaving Heroics
Professor Israel Meizner, head of
the Ultrasound Unit at Rabin
Medical Center's Hospital for
Women, has performed thousands
of ultrasounds and invasive procedures
on pregnant women throughout
his long career, but nothing like
the extraordinary ultrasound of
Limor Agamy.